Naltrexone Maintenance Treatment of Alcoholism
Completed · Phase 4 · Has a placebo group
Conditions studied: Alcoholism
In brief
The purpose of this study is to determine the long-term effectiveness of naltrexone treatment in alcohol-dependent patients who respond to short-term treatment. Those who respond to short-term treatment will be randomized to a 1-year, double-blind, placebo-controlled maintenance phase with a 6-month posttreatment followup.
Key facts
- Study ID
- NCT00000450
- Run by
- The Scripps Research Institute
- People needed
- 159
- Starts
- 1997-04-10
- Expected to finish
- 2002-02-13
- Last updated by the study team
- 2017-04-20
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Meets criteria for alcohol dependence.
- Expresses a desire to cut down or stop drinking.
You may not qualify if…
- Currently meets criteria for dependence on substances other than alcohol.
- History of opiate dependence or evidence of current opiate use.
- Significant medical disorders that will increase potential risk or interfere with study participation.
- Liver function tests more than 3 times normal or elevated bilirubin.
- Female patients who are pregnant, nursing, or not using a reliable method of birth control.
- Inability to understand and provide a consent form.
- Treatment with an investigational drug during the previous month.
- Prior treatment with naltrexone.
- Chronic treatment with any narcotic-containing medications during the previous month.
- Sensitivity to naltrexone as evidenced by adverse drug experiences especially with narcotic containing analgesics or opioid antagonists.
- Current treatment with disulfiram.
- More than 6 weeks of abstinence.
- Meets criteria for a major psychiatric disorder and is in need of, or currently undergoing pharmacotherapy.
Where it is running
- Department of Psychiatry, University of Miami School of Medicine — Miami, Florida, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.